Search, analyze & compare

My selected companies

Adjust valuation method
WatchlistNameTickerP/EP/SP/BEV/EbitdaROEROICRSISMA200DCFVolumeClosing price
-
Guardant Health IncGH-7.845.80-2,495.41-10.11-609.28%-19.64%40.11$23.50$92.8676,656$32.65

Detail of Guardant Health Inc

 
CEO
Dr. Helmy Eltoukhy Ph.D.
Employees
1768
Industry
Diagnostics & Research
Sector
Healthcare
Market cap
$4B

Company details

Guardant Health Inc. is an innovative biotechnology company specializing in the development and commercialization of precision oncology diagnostics. This company is recognized for its groundbreaking work in non-invasive cancer detection through liquid biopsy technologies, which involve analyzing circulating tumor DNA in blood samples. Guardant Health’s primary function is to provide oncologists and researchers with critical tools and data to better understand cancer, tailor treatments, and monitor disease progression, potentially improving patient outcomes significantly. Guardant Health operates prominently in the healthcare and biotechnology sector, significantly impacting fields such as cancer research and personalized medicine. Their products and services are vital for facilitating early detection of cancer, identifying treatment options, and offering companion diagnostics for pharmaceutical developments. In the financial market, Guardant Health represents an important player within the precision medicine landscape, influencing investment within the biotechnology and healthcare sectors. Founded in 2012 and headquartered in Redwood City, California, the company continues to expand its portfolio and advance its technologies, playing a pivotal role in the fight against cancer at a global level.

Revenue
Cost of goods
Gross profit
OE
R&D
G&A
OI
OIE
PI
TAX
NI
Revenue (Rev)
$739.02M
Cost of goods (CoG)
-$289.80M
Gross profit (GP)
$449.22M
Operating expense (OE)
-$892.81M
Research and development (R&D)
-$347.75M
General and administrative (G&A)
-$545.06M
Operating income (OI)
-$443.59M
Other income expense (OIE)
-$42.60M
Pretax income (PI)
-$435.09M
Tax (TAX)
-$1.28M
Net income (NI)
-$436.37M
Guardant Health Inc
GH • XNGS • US
$32.65
+15.52 (90.60%)
Stock vs Industry average
  • Industry average

Negative values are hidden from the graph.
Trailing annual dividend rate
$0.00
Payout ratio
0.00%
EPS
-$3.55
Margin profit
-74.02%
52 week low
$16.07
52 week high
$36.290001
50-day simple moving average
$0.00
200-day simple moving average
$23.50
Percent held by insiders
4.74%
Percent held by institutions
98.23%
Dividend yield
0.00%

Change of shares

Cash vs Debt

Insider Trading

Comparison of selected companies

 
%
Price change
GH +90.60%
eps change
GH 0.00%